Programme

Jagat Narula, MD, PhD, MACC, FRCP is currently the executive vice president and chief academic officer at UTHealth Houston. He works with the six deans and members of the UTHealth Houston leadership team to advance the academic mission and promote excellence in education and research. This includes leading a diverse team of faculty and administrators to oversee strategic planning and implementation of the university’s education and research platform. Dr. Narula after completing his cardiology fellowship training and PhD (Cardiovascular Immunology) from the All India Institute of Medical Sciences, Delhi, relocated to Massachusetts General Hospital (MGH) and Harvard Medical School in 1989. At MGH, after cardiology, heart failure & transplantation, and nuclear cardiology fellowships and he joined the cardiology faculty. In 1997, he moved to Hahnemann University School of Medicine, Philadelphia, where he was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the department of Internal Medicine, and Director of Heart Failure & Transplantation Center. He subsequently joined University of California, Irvine School of Medicine (2003) as Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine’s Douglas Hospital. He was also the Director of Memorial Heart & Vascular Institute, Long Beach Memorial Hospital, and Medical Director of the Edwards Lifesciences Center for Advanced Cardiovascular Technology in UC Irvine’s Henry Samueli School of Engineering. He moved to Mount Sinai as the Philip J. and Harriet L. Goodhart Chair in Cardiology, and the Director of Cardiovascular Imaging Program in the Mount Sinai’s Zena and Michael A. Wiener Cardiovascular Institute in 2011. Dr. Narula has the unique distinction of being able to combine molecular and subcellular pathology and imaging with clinical imaging of the failing myocardium and high-risk coronary atherosclerotic plaques to develop novel strategies for prevention of cardiovascular disease and promotion of cardiovascular health in developed as well as developing countries. He has specifically contributed to two major areas including heart muscle cell apoptosis in heart failure, and lipid-rich atherosclerotic plaques that are susceptible to rupture and acute coronary events. He has brought novel experimental strategies to bedside and defined their applicability at the community level. He is currently actively involved in numerous population-based heart attack prevention programs including HAPPY [Heart Attack Prevention Program for You]. Based on his expertise in global medicine, he serves on the Advisory Council on Global Prevention of Cardiovascular Diseases of the Institute of Medicine of the National Academies of Sciences. His research has been funded, in part, by the grants from National Institutes of Health. He is considered to be a true translationist and one of the infrequent investigators who has distinction of publishing in the best basic science and the best clinical journals including Science, Nature Medicine, PNAS, New England Journal of Medicine, Lancet, Circulation and JACC. With more than 1000 original research publications or presentations to his credit and more than 35 books or journal supplements edited, Dr. Narula has been awarded as ‘the best young investigator’ on several occasions for his research contributions. His mentoring prowess is exemplified by the fact that 20 of his fellows, working in his research laboratory, have been awarded young investigator awards. He was recently awarded as the Best Educator as also the Innovator in Cardiovascular Medicine by the American College of Cardiology in the year 2012, and was honored as the Master of the American College of Cardiology in March 2013. He has just received the Distinguished Scientist Award 2015 from the American College of Cardiology.

As an Independent Senator in the Parliament of Barbados, appointed by His Excellency, the President of Barbados, and President of the Healthy Caribbean Coalition, I am committed to driving initiatives that address non-communicable diseases and improving public health in the Caribbean region. I bring a wealth of experience in medicine, medical education, and digital media, alongside credentials as a Fellow of the Royal College of Physicians and Fellow of the American College of Physicians. With over three years as Deputy Dean of Recruitment & Outreach at The University of the West Indies, I have contributed to fostering talent and promoting diversity in medical education. My expertise in clinical pharmacology and internal medicine, coupled with a strong foundation in digital media, guides my efforts to collaborate with civil society organizations and global leaders in advancing healthcare outcomes.

Hjärt-Lungfonden has benefited from over 11 years of leadership, with initiatives focused on funding transformative research and promoting public health. By leveraging expertise in PR and organizational leadership, the organization has advanced its mission to combat cardiovascular and pulmonary diseases. Through collaborative efforts and data-driven strategies, the team has empowered impactful healthcare innovations and strengthened public awareness. With a dedication to fostering partnerships and sustainable solutions, Hjärt-Lungfonden is making strides to improve lives and support critical medical advancements.

Dr. Lilian Mbau is a Medical Doctor and Public Health expert specializing in Preventive Cardiovascular Medicine. Currently serving as the Executive Director of the Centre for Cardiovascular Prevention and Rehabilitation (CCPR), she is committed to elevating the priority of cardiovascular disease (CVD) prevention and rehabilitation in Kenya and the broader region. Previously, she held the role of Chief Executive Officer at the Kenya Cardiac Society (KCS). Following her medical training, Dr. Mbau pursued a Master of Public Health degree at Moi University and a Master of Science in Preventive Cardiovascular Medicine from the University of South Wales. Additionally, she holds a certification in cardiac rehabilitation from the University of Wisconsin. She is an active member of the Kenya Cardiac Society, European Association of Preventive Cardiology (EAPC) and the International Council for Cardiovascular Prevention and Rehabilitation (ICCPR).

Tanya Hall has over 17 years of experience in the not-for-profit sector, founding Hearts4heart in 2011 after her personal experience with heart disease. As CEO, she has transformed the organization into a leading voice for patient support, education, and advocacy across Australia and New Zealand. Tanya has influenced health policy, expanded access to therapies, and fostered global collaborations with clinicians, policymakers, and industry leaders. She has played a key role in Australia’s focus on patient access to therapies, uniting stakeholders through roundtables and teleconferences. Her goal is to foster stronger collaborations to ensure equitable access to heart health education, prevention, and treatment. Tanya has served on key committees, including the Therapeutic Goods Administration Device Reform, and co-authored several Australian clinical guidelines. Her advocacy work has earned her numerous awards, including the 2023 Advocacy Champion of the Year and Health Industry Hub’s ‘Catalyst for Change’ award.

20+ years of experience in policy advocacy, global health capacity building and health systems strengthening initiatives at the community, hospital and government levels. • Led collaborative efforts in many global and cultural settings with diverse groups of stakeholders, including clinicians, hospital administrators, government officials and policy makers, and patient and family representatives. • Specialized and tertiary health care and quality improvement. • NGO management: strategic planning, operations, governance, program development and evaluation, financial management, donor relations and proposal development. • Built and managed successfully teams, remote and in-person multidisciplinary health team projects in several countries. • Regularly published author in academic and nonacademic journals (https://orcid.org/0000-0002-3209-0261) and invited speaker at international meetings. • Passionate about international development and global health. Thought leader, advocate, strategic partner, connector and catalyst for change. Always learning!

Professor Dorairaj Prabhakaran is an eminent cardiologist, epidemiologist and academician of global repute. He moved beyond the conventional world of clinical cardiology to advance science in the prevention of heart diseases and diabetes in India so that his work could benefit millions of people in this country. He is currently Executive Director, Centre for Chronic Disease Control and the President-Elect of the World Heart Federation. Prof. Prabhakaran has more than 750 publications in prominent scientific journals and has an H‐Index of 126. His work spans from understanding the pathways as to why Indians have a high propensity to CVD and diabetes, the role of air pollution and climate change in chronic diseases, identifying low-cost solutions including digital health, telemedicine and AI, and large-scale capacity building of researchers and physicians. His exceptional contributions spanning Science, Medicine, and Public Health have catapulted the field of Preventive Cardiology in India.

Building the future of cardiovascular health for the 21st century. Naman Gosalia is leading a bold, system-level movement to transform heart care from a reactive, symptom-driven model into a world where prevention is the default. He is driving a national and global effort in primary cardiovascular prevention, uniting clinicians, researchers, hospitals, and public-health systems toward one purpose: to save lives before disease ever has the chance to begin. His philosophy is simple and revolutionary: the measure of great healthcare is not how well we treat emergencies but how few emergencies ever reach our doors. Instead of expanding ICUs, he is building the frameworks that ensure fewer people ever need one. Instead of waiting for the heart to fail, he is championing lifelong cardiovascular profiles that allow doctors to intervene early, precisely, and confidently. This mission is rewriting the future of cardiac care aiming to make “sudden heart attack” a phrase the world no longer needs. Every hospital wants clarity. Every doctor wants foresight. Every family deserves prevention. And leadership means creating the world where all three become the standard, not the aspiration. Let’s save lives. Together.

I believe evidence should do more than inform. It should move people. I partner with clients across global health, development, private and policy sectors to design programs that translate evidence into action. My work sits at the intersection of research and influence: conceptualizing ideas that resonate, building the strategy to bring them to life, and overseeing delivery that meets the highest standards of rigor and relevance. In practice, that means shaping and executing strategy efforts, leading rapid and deep-dive research, developing frameworks and practical tools, and bringing findings to the audiences that matter most, whether on the global stage, in closed-door roundtables with senior decision-makers, or through digital platforms designed to reach beyond the usual rooms. I have been recognized for my leadership and impact across multiple global platforms, including being named a Boston Congress of Public Health 40 Under 40 honoree and being featured in the New York City Daily. I recently served on the Board of the World Health Summit Council and am the founder of NomNom Babies, a social impact venture advancing early childhood nutrition in West Africa. What drives me is impact that compounds. I measure success not by the quality of a report alone, but by whether it shifted how a policymaker thinks, whether it gave a patient community a stronger voice, and whether it moved an organization’s mission forward in a way that lasts. With a DrPH in health policy and leadership from LLU, an MPH from Harvard, and an Executive MBA from Oxford Saïd Business School, I bring both the analytical depth and the strategic range to work across sectors, geographies, and scales of ambition.

Lynnette M. Neufeld.  Dr Neufeld is Director of the Food and Nutrition Division at FAO, and past President of the International Union of Nutrition Scientists (IUNS). Her career has been committed to improving nutrition outcomes through the generation and utilization of evidence to enhance policy and programme design and delivery across multiple sectors. She began in an academic position at the National Institute of Public Health, Mexico, then led research and evaluation units in nutrition-focused NGOs before joining FAO in early 2022.

Bilingual senior advocacy and government affairs professional with two decades of domestic and international experience in the non-profit sector. Diversity, equity, and inclusion professional with an understanding of global health and developing advocacy, thought leadership strategies, and initiatives coupled with strategic partnerships. Expert in project management, coalition building, training, and facilitation to effectively manage and work with multicultural audiences. Demonstrated excellence in verbal and written communication skills. Specialties: Non-profit management, program development and implementation, policy advocacy, civil society engagement, patient advocacy, donor relations, board management, resource development, patient engagement, diversity, equity and inclusion, and volunteerism.

Dr. Tom Frieden is a physician trained in internal medicine, infectious diseases, public health, and epidemiology. Dr. Frieden is now the President and Chief Executive Officer of Resolve to Save Lives, which works with partners to accelerate action against the world’s leading health threats and save millions of lives Dr. Frieden was the Director of the Centers for Disease Control and Prevention (CDC) from 2009 – 2017. At the CDC, Dr. Frieden oversaw the work that helped end the 2014 West Africa Ebola epidemic. He began his public health career in New York City confronting the largest outbreak of multi-drug resistant tuberculosis to occur in the US. He was then assigned to India, on loan from the Centers for Disease Control and Prevention, where he helped scale up a program for effective tuberculosis diagnosis, treatment, and monitoring. Asked to return to New York City to become Mayor Mike Bloomberg’s Health Commissioner, he directed efforts to reduce smoking and other leading causes of death that increased life expectancy by 3 years.

Scientist working on climate change and health since 1999. Head of the Climate Change and Health Unit at the World Health Organization since 2010, coordinating across WHO’s leadership, technical and country support work to advance health protection from climate risks, and to gain the huge health benefits that come from a transition to clean, cheap and sustainable energy sources . Lead author on three reports of the Intergovernmental Panel on Climate Change, Member of the UN National Academies of Medicine. Occasional cyclist for individual and public health, for the planet, and for pleasure. On Bluesky at @diarmidcl.bsky.social

+20 years experience in public-private partnership, corporate sustainability strategy and communication. Specialties: Social partnerships and strategic stakeholder engagement, Corporate sustainability strategy and communication, NCD prevention and health promotion, childhood obesity, environmental/climate communication and advocacy, green accounts, eco-labels, training and education, private sector development Africa and Asia

Dr Haileyesus Getahun is the Founder and CEO of the Global Centre for Health Diplomacy and Inclusion (CeHDI), a Geneva-based foundation dedicated to amplifying the priorities and voices of the Global South in global health governance, advancing the right to health, and global health equity. He also serve as the founding CEO of the Health Development Partnership for Africa and the Caribbean (HeDPAC), an initiative established in the wake of the COVID-19 pandemic to strengthen South-South cooperation and strategically aligned health partnerships between Africa and the Caribbean. Prior to these roles, Dr Getahun was the founding Director of the Global AMR Coordination and the Quadripartite Joint Secretariat on Antimicrobial Resistance (AMR), hosted by the World Health Organisation and bringing together FAO, UNEP, WHO, and WOAH. In this capacity, he led the global One Health, multisectoral response to AMR and guided the establishment of the Global Leaders Group on AMR, the AMR Multi-Stakeholder Partnership Platform, and the AMR Multi-Partner Trust Fund—three landmark global structures that transformed the global AMR response. During his tenure, he drove several high-impact innovations in the global AMR agenda, including the transformation of World Antibiotic Awareness Week into World AMR Awareness Week, now observed annually from 18–24 November; and the development of the Priority One Health Research Agenda for AMR. Dr. Getahun also served as Director of the Secretariat of the United Nations Interagency Coordination Group on Antimicrobial Resistance, established by the UN Secretary-General and coordinated the landmark 2019 report that helped shape the global policy and political responses to AMR. Earlier in his career, he held senior leadership roles in WHO’s Global Tuberculosis Programme, leading the organization’s work on TB/HIV and community-based care worldwide, including authoring the 2004 interim TB/HIV policy, whose implementation helped avert an estimated 9.8 million deaths between 2005 and 2024. Across his career, Dr Getahun has led international teams, shaped global health policy, convened senior political leaders, and built high-impact partnerships and institutions across the UN system, governments, and global institutions.

I’m a global non-profit executive, operator, and strategist with over 20 years of experience leading complex, multi-country organizations across Africa and beyond. Currently, I serve as Co-CEO of Financing Alliance for Health, where I work at the intersection of strategy, operations, governance, and resource mobilization; helping mission-driven initiatives move from vision to execution. My work spans organizational design, fiscal sponsorship, donor partnerships, risk management, and building systems that allow organizations to scale sustainably while staying rooted in local leadership. A consistent thread in my career has been strengthening the “backbone” of impact : structures, people, processes, and funding models that make good ideas last. Alongside my executive role, I’m passionate about mentoring and knowledge-sharing, particularly with women navigating leadership, career growth, and work-life integration. I believe ambition and balance are not mutually exclusive, and that clarity, systems, and self-trust are powerful tools for building a life and career by design. I’m known for being strategic, grounded, and deeply collaborative and able to zoom out to big-picture vision while staying close to the operational details that matter. If you’re interested in conversations on non-profit leadership, governance, systems thinking, or designing a career with intention, you’re in the right place.

A public health advocate and civil society leader passionate about advancing health equity and meaningful youth participation. With more than a decade of experience in social impact and health promotion and advocacy, I currently serve as Program director of CAZAS and President of the International Youth Health Organization, where I lead efforts to strengthen health services and policies and youth engagement in health policy and program development across Montenegro, Europe and beyond. My journey began in Montenegro as a youth health educator, and over the years I’ve had the privilege to coordinate national and international initiatives addressing HIV prevention, mental health, reproductive rights, and non-communicable diseases. What drives me most is creating spaces where citizens, especially youth, can influence decisions that shape their wellbeing. I believe that inclusive, transparent, and forward-thinking health systems start with empowered individuals who dare to reimagine how health and equity are defined.

I am a development professional working at the intersection of youth engagement, food systems, and sustainable land-use management. My work is grounded in a community-based approach that recognizes the interlinkages between livelihoods, governance, climate, and ecosystems. I have experience coordinating multi-country programs, producing knowledge products, engaging with stakeholders, and advancing sustainability initiatives across Africa and globally. I am an experienced speaker and facilitator, with a strong foundation in convening stakeholders and organising international workshops and high-level events, ensuring meaningful youth participation in global policy spaces. I hold an MSc in International Development Studies from Wageningen University & Research with a specialization in Politics and Governance of Development and additional training in Sustainable Development Diplomacy. I also hold a BSc in Geography from King’s College London, which laid a strong foundation in environmental dynamics and human–environment interactions.

I am a final semester medical student at the Federal University of Paraná, serving as Liaison Officer for Public Health Issues of the IFMSA. I was a member of the national public health team for two years and local coordinator for six, coordinating various activities in public health, human rights, medical education, and reproductive health. I was the founder and president for two years of the Academic League of Public Health at UFPR (LIASC), and throughout my academic career, I have researched various topics, such as Chagas disease, malaria, immunization, and epidemiology.

I was diagnosed with non-obstructive hypertrophic cardiomyopathy at the age of 24, even though I had always known there was something wrong. At the time I was graduating in physical education, and the news made me wonder if I was taking the right path. With my head in the world I decided to fly away, to Australia and then London, to work and explore things. It took me quite a while to understand and accept that what was happening was serious, at first taken lightly. Back to Italy in 2019, where I now live and work, I was strongly advised to implant an S-ICD as a parachute due to the worsening of the disease, which I accepted even if thinking that it would never be necessary. Otherwise, it saved my life. It is in this circumstance that I decided to open an Instagram page “livingwiththeS-icd” where I support and inspire people worldwide and maintain close correspondence with patients and their relatives facing similar problems and decisions. Accepting the disease without letting it ruining their life. I am also part of HCM Patients Foundation Europe, with the aim to unite and support patients and their families in the European Union. I’m an experienced project manager working at the intersection of the arts, wellness and legal affairs. I work across the whole project process, from programme design and concept development to delivery and project evaluation. Having lived and worked in the United Kingdom, Italy and Australia, I enjoy adapting projects to different contexts and using each as an opportunity to broaden cultural horizons.

I am a creative and dynamic Medical Doctor focused on bringing the first infrastructure for biology ASI

Clara Chow is a Cardiologist at Westmead hospital, Professor of Medicine, at the University of Sydney, and Academic Director of the Westmead Applied Research Centre. At Westmead, she is Program Director, Community Based Cardiac Services with responsibilities for the Rapid Access Cardiology Services which she instigated in 2015. She also hold honorary roles as the Academic co-Director CPC Westmead, and professorial fellow at the George Institute for Global Health. She was President of the Cardiac Society Australia and New Zealand in 2021-3 and its first female president. She was the inaugural Director of the Australian Stroke and Heart Research Accelerator. She has a PhD from the University of Sydney, Australia in cardiovascular epidemiology and international public Health and a Postdoc from McMaster University, Canada. Clara’s research focuses on the prevention of cardiovascular disease, innovation in delivery of cardiovascular care and the design and evaluation of digital health interventions. Her research track includes >350 scientific publications including papers in top-tier journals such as Lancet, JAMA and NEJM. Clara was appointed a Member of the Order of Australia (AM) in 2023. She currently serves on the Boards of the WSLHD and the National Heart Foundation. Her clinical interests are in cardiac imaging particularly cardiac CT and echo.

Dr. Xavier did his medical training at St. John’s Medical College, Bangalore, India, and did a Masters in Clinical Epidemiology and Biostatistics at McMaster University, Canada. About 25 years back, he helped set up the first large cardiovascular collaboration in 220 centers in India and recruited 120,000 participants in 52 major projects. They include multi-centre observational studies in cardiovascular disease to determine burden, risk factors and treatments. The clinical trials involve anticoagulants, lipid lowering agents, anti-hypertensives, antiplatelet agents, polypills and the impact of non-medical health workers and m-Health in cardiovascular prevention. He has or is serving on about 36 international research steering committees.

I am a member of the Global Preparedness Monitoring Board and co chair of The World Health Summit Council. I am director of the digital transformations for Health LAB. I advise on matters of global health governance and have launched training in global health diplomacy. I have contributed to as well as initiated many global health innovations. Present interests relate to health and geopolitics, planetary health and digital determinants of health.

Robert Marten is the Partnership and Strategy Officer at the Alliance for Health Policy and Systems Research at the World Health Organisation in Geneva, Switzerland. He previously worked in the WHO India Country Office on primary health care advising the Ministry of Health and Family Welfare. Before this he was a Council on Foreign Affairs (CFR) Hitachi Fellow based at the Japan Center for International Exchange (JCIE) studying Japan’s role in global health. Before this, he was the Health Systems Cluster Coordinator for WHO in Sierra Leone, where he managed a team advising the Ministry of Health and Sanitation on health systems strengthening post-Ebola and was part of WHO Sierra Leone’s Senior Management Team. In the past, he worked at the Rockefeller Foundation in New York on Transforming Health Systems (THS) for close to six years. He managed a $20-million grant portfolio focused on global health policy, including the Foundation’s response to the Ebola crisis. Robert coordinated efforts to embed health systems and universal health coverage within the post-2015 development agenda. Before this, Robert consulted with the World Bank, the World Health Organization, and German Technical Cooperation in Zambia and South Africa. He worked as a researcher at the Global Public Policy Institute in Germany and served as a United Nations Volunteer on HIV/AIDS in Vietnam. He has published close to 100 articles in the Lancet, BMJ Global Health, Public Health, Health Policy and Planning, the WHO Bulletin and other journals. He has served on the Board of Directors of the Global Health Council, and on the Advisory Council of the Young Professionals Chronic Disease Network. Robert received a bachelor’s degree from McGill University, a master’s degree in public policy from the Hertie School of Governance, a certificate in global health effectiveness from the Harvard School of Public Health, a master’s degree in public health from Johns Hopkins University, and a doctoral degree from the London School of Hygiene and Tropical Medicine.

Cardiac Surgeon and Inventor of the transapical access for TAVI. This medical technology has saved over 30’000 lives. Serving as one of the most experienced cardiac surgery chiefs of Switzerland. Pioneer of transcatheter valve therapies and editor of the first textbook called Transcatheter Valve Therapies he significantly contributed to the expansion of one of the most promissing field in cardiovascular medicine. He founded Endoheart AG, A Swiss medtech start-up active in the field of cutting edge endovascular therapies for the cure of heart disease. Christoph Huber is serving as vice president of the swiss society of cardiac surgery.

Amiee Aloi is a leading international public policy and government affairs professional with particular expertise in health policy and development. Amiee is currently Executive Director, Global Public Policy at Merck. Previously, she was Director, Advocacy and Government Relations at Gates Ventures, the private office of Bill Gates. Prior to that, she was Deputy Vice President for International Advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA), the leading industry association representing innovative global biopharmaceutical companies. In this capacity, Amiee was responsible for strategic planning, implementation, and coordination of the biopharmaceutical association’s advocacy efforts that address industry’s international trade priorities. Amiee has strong analytical skills, particularly with respect to legislation, trade, and policy documents, and strong written and verbal communication skills. She has lived in Delhi, India and has a deep understanding of the business and political environment in Asia. Previously, she worked as Associate Vice President at PhRMA where she lead industry’s advocacy activities in India across a range of policy issues including intellectual property and innovation, market access and pricing, and clinical research. She’s also worked as Director of Policy at PhRMA where she worked to promote strategies demonstrating the value of innovative medicines across the U.S. health care system, including Medicare, Medicaid, Veteran’s Affairs, and health insurance exchanges. Prior to joining PhRMA, Amiee worked at Avalere Health, a leading healthcare advisory company, where she provided research and analysis on coverage, reimbursement, and policy issues facing biopharmaceutical and medical device companies. Specialties: policy, international affairs, India, advocacy, pharmaceutical policy, trade policy, public health policy, international development, intellectual property policy, access to medicines policy, stakeholder engagement strategy, government relations, advocacy and strategy development.

Rony Shimony MD, FACC is currently the Director of Cardiology at Atria Institute, and a Cardiologist at The Mount Sinai Hospital. Until June 2022, he served as the Director of Clinical Cardiology at Mount Sinai West Hospital (MSW), part of Mount Sinai Heart, Cardiovascular Institute with the leadership of world renowned Dr. Valentin Fuster, Dr. Jonathan Halperin, Dr. Jagat Narula, and Dr. Samin Sharma. The internationally renowned Mount Sinai Health System, outstanding Medical School, Residencies, Fellowship programs, encompasses a full range of cardiovascular services including cardiovascular prevention, complex cardiac ,coronary, valvular, and peripheral interventions, full cutting edge electrophysiology services, device implantation and complex ablations, womens health, genetic center, advanced heart failure and heart transplant program with a comprehensive cardiothoracic surgical program lead by Dr David Adams.

Top level executive management . Global health leadership. Substantial political insight and understanding. Implementation of politically decided, very extensive reorganization in the public health sector, Norway. Many years of experience as chair and member of boards. Quality improvement, strategic planning, health care management, change-management, management and leadership development, R&D, innovation, corporate governance, business establishment and development. Extensive experience in building networks and involving partners, stake-holders, organizations and patients. In=country implementation and partnership building Strategic, result-oriented, team- and partnership builder. Always looking for innovation and quality improvement creating added value at country and community level. Specialties: MD, MHA, Specialist in Obstetrics and Gynaecology

Multi-faceted Executive with over 15 years of experience living, studying and working in international environments (Europe, Canada, Africa, Latin America). Expertise in implementing robust health and sustainable development policies in low and middle income countries. Specialties: non-profit leadership, stakeholder engagement, strategic partnerships, governance, strategic planning, political outreach and diplomatic relations, fundraising Topics: sustainable development, global health, tobacco control, non-communicable diseases, financing for development, poverty reduction

David Lloyd is CEO of the National Heart Foundation of Australia. He is concurrently a Board member and Vice President (Elect) of the World Heart Federation in Geneva; Chair of the Timor Leste Hearts Fund; a board member of the Global Cardiovascular Research Funders Forum; and a board member of Momentum Triathlon Academy. Prior to joining the Heart Foundation, he served as founding CEO of the South Australian Immunogenomics Cancer Institute at the University of Adelaide, CEO of Jean Hailes for Women’s Health, Chief Operating Officer of the Baker Heart Research Institute, and CEO of the University of Melbourne’s commercial subsidiaries Melbourne Enterprises International and Melbourne University Private. He is a keen but strictly amateur endurance sport enthusiast.